Ocular Therapeutix™ Announces Topline Results for Phase 2 Clinical Trial of OTX-CSI for the Treatment of Dry Eye Disease Did Not Meet Primary Endpoint
The Phase 2, U.S.-based, randomized, double-masked, multi-center, vehicle-controlled clinical trial [...]